Ionis Pharmaceuticals reported 396.15 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Arrowhead Research 39.19 0 Jun/2026
Astellas Pharma 9.57 0.16 Sep/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Celltrion 41.5 17.47 Jun/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Divis Laboratories Ltd 84.22 25.87 Sep/2026
Exelixis 18.43 0.41 Sep/2026
Halozyme Therapeutics 16.12 3.61 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 1.11K 0 Jun/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Neurocrine Biosciences 83.17 61.07 Sep/2026
Novartis 19.17 3.24 Sep/2026
OPKO Health 40.35 0.42 Jun/2026
Organigram Holdings 15.55 3.54 Jun/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 15.2 3.72 Sep/2026
Pharma Mar 24.29 7.94 Sep/2026
PTC Therapeutics 8.76 0 Jun/2026
Qiagen NV 23.09 6.37 Sep/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sarepta Therapeutics 32.09 22.66 Sep/2026
Sartorius 47.29 5.7 Sep/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Vertex Pharmaceuticals 29.35 1.3 Sep/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 39.33 3.06 Sep/2026